The monoclonal antibody (mAb) B3 recognizes an antigen found on the su
rface of many adenocarcinoma cells. While the structure of the cellula
r antigen is unknown, epitope mapping using neoglycoproteins with know
n carbohydrate moieties indicates that the mAb B3 reacts with the Lewi
s(Y) (Le(Y)) antigen [Pastan et al., Cancer Res. 51 (1991) 3781-3787].
We have used mAb B3 to select for peptides that mimic the carbohydrat
e structure using libraries of filamentous phage displaying random pep
tides on their surface. Phage that were selected coded for the sequenc
e APWLYGPA. The corresponding peptide was synthesized and tested for i
ts ability to bind to mAb B3. The peptide was found to inhibit specifi
cally the binding of In-111-labeled mAb B3 to A431 adenocarcinoma cell
s, as well as to inhibit killing of these cells by a B3 immunotoxin. I
n addition, the Le(Y) carbohydrate, lactodifucotetraose, was able to c
ompete with the phage displaying this peptide for binding to mAb B3. A
lanine-scanning mutagenesis of the sequence coding for this peptide in
dicates that four residues, PWLY, were critical for binding to the mAb
. The sequence is similar to other sequences known to mimic carbohydra
te structures.